Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    NCT00839436
Show Display Options
Rank Status Study
1 Terminated Interleukin-7 (CYT107) Treatment of Idiopathic CD4 Lymphocytopenia: Expansion of CD4 T Cells (ICICLE)
Condition: Idiopathic CD4+ T-Lymphocytopenia
Intervention: Drug: CYT107

Indicates status has not been verified in more than two years